 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
Date |
Open |
High |
Low |
Close |
Volume |
08/04/2022 |
$1.35 |
$1.43 |
$1.29 |
$1.43 |
148.20K | 08/05/2022 |
$1.45 |
$1.54 |
$1.36 |
$1.44 |
186.50K | 08/08/2022 |
$1.53 |
$1.55 |
$1.51 |
$1.54 |
109.10K | 08/09/2022 |
$1.60 |
$1.60 |
$1.50 |
$1.52 |
93.20K | 08/10/2022 |
$1.55 |
$1.55 |
$1.50 |
$1.52 |
16.10K |
 |
Acer Therapeutics is a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for rare and life-threatening diseases. Co.'s pipeline includes four programs: ACER-001 (sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle disorders and Maple Syrup Urine Disease; ACER-801 (osanetant) for the treatment of induced vasomotor symptoms; EDSIVO (celiprolol) for the treatment of vascular Ehlers-Danlos syndrome in patients with a confirmed type III collagen mutation; and ACER-2820 (emetine), a host-directed therapy against a variety of viruses, including cytomegalovirus, zika, dengue, ebola and COVID-19. | |
 |

Acer Therapeutics (ACER) has the following price history information. Looking back at ACER historical stock prices for the last five trading days, on August 04, 2022, ACER opened at $1.35, traded as high as $1.43 and as low as $1.29, and closed at $1.43. Trading volume was a total of 148.20K shares. On August 05, 2022, ACER opened at $1.45, traded as high as $1.54 and as low as $1.36, and closed at $1.44. Trading volume was a total of 186.50K shares. On August 08, 2022, ACER opened at $1.53, traded as high as $1.55 and as low as $1.51, and closed at $1.54. Trading volume was a total of 109.10K shares. On August 09, 2022, ACER opened at $1.60, traded as high as $1.60 and as low as $1.50, and closed at $1.52. Trading volume was a total of 93.20K shares. On August 10, 2022, ACER opened at $1.55, traded as high as $1.55 and as low as $1.50, and closed at $1.52. Trading volume was a total of 16.10K shares.
ACER Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acer Therapeutics shares, starting with a $10,000 purchase of ACER, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
08/14/2012 |
|
End date: |
08/10/2022 |
|
Start price/share: |
$5.10 |
|
End price/share: |
$1.52 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-70.20% |
|
Average Annual Total Return: |
-11.41% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$2,979.44 |
|
Years: |
9.99 |
|
|
 |
Date |
Close |
08/04/2022 | $1.43 | 08/05/2022 | $1.44 | 08/08/2022 | $1.54 | 08/09/2022 | $1.52 | 08/10/2022 | $1.52 |
|
 |